Revenue: US$28.8b (up 6.0% from FY 2023). Net income: US$480.0m (down 92% from FY 2023). Profit margin: 1.7% (down from 21% in FY 2023). EPS: US$0.39 (down from US$4.54 in FY 2023). Revenue ...
Feb 11 (Reuters) - Gilead Sciences (GILD.O), opens new tab posted fourth-quarter results that exceeded Wall Street expectations and forecast 2025 earnings above analyst estimates on Tuesday ...
Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments. A key highlight was the robust performance in the HIV and oncology segments ...
Gilead Sciences (NASDAQ:GILD), a major player in the biotechnology sector, reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 11, that topped analysts' consensus estimates.
According to the Hebron Fire Department, at around 4:48 p.m. firefighters and troopers were deployed to the scene of Gilead Street for reports of a two-car accident involving a rollover.
Her work has previously appeared in Billboard and Reader's Digest. Jamie McCarthy/WireImage Josh Gad shared that he’s taking a GLP-1 medication for weight loss, praising it as a “miracle drug ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Renowned investigative journalist Manasseh Awuni Azure has accused President Mahama of shielding former government officials accused of corruption. According to him, Mahama’s mass ...
(RTTNews) - Gilead Sciences (GILD) announced that the FDA has accepted its New Drug Application submissions for lenacapavir-the twice-yearly injectable HIV-1 capsid inhibitor-for the prevention of ...
Apple and Intel also managed modest gains, helping limit losses in the Nasdaq Composite. Daily Gilead Sciences, Inc CVS Health surged 13.6% after posting stronger-than-expected Q4 earnings ...
"It was amazing to have that opportunity to just sit with him," Gad said, describing the reunion as "very cathartic" Erin Clack is a Staff Editor for PEOPLE. She has been writing about fashion ...
Josh Gad is opening up about the weight loss success he’s had with GLP-1 medication — and sharing some of the conflicted feelings he’s had along the way. “I’m on a GLP-1 … this is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results